CRT 2026
Atherosclerosis and Lipids
Takashi Akasaka, MD, PhD
Senior Consultant
Nishinomiya Watanabe Cardiovascular Cerebral Center
Nishinomiya, Hyogo, Japan
Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 18, 2025)
Rasha Al-Lamee, MA, MD, PhD
Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom
Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Jannsen: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Renu Virmani, MD
President
CVPath Institute, Inc.
Gaithersburg, Maryland, United States
Disclosure information not submitted.